EPHX2 Inhibits Colon Cancer Progression by Promoting Fatty Acid Degradation

被引：21
作者：
Zhou, Yiran [1 ,2 ]
Li, Xiao [1 ,2 ]
Guan, Aoran [1 ,2 ]
Zhou, Haodong [1 ,2 ]
Zhu, Yankun [1 ,2 ]
Wang, Ruotian [1 ,2 ]
Li, Ruhong [1 ,2 ]
机构：
[1] Kunming Med Univ, Yanan Hosp Kunming City, Dept Gen Surg, Yanan Hosp, Kunming, Yunnan, Peoples R China
[2] Key Lab Tumor Immunol Prevent & Treatment Yunnan, Kunming, Yunnan, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
EPHX2; CRC; metabolic reprogramming; fatty acid degradation; ROS; lipid droplet; SOLUBLE EPOXIDE HYDROLASE; METABOLISM; ROLES; CELLS;
D O I：
10.3389/fonc.2022.870721
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor cells use metabolic reprogramming to keep up with the need for bioenergy, biosynthesis, and oxidation balance needed for rapid tumor division. This phenomenon is considered a marker of tumors, including colon cancer (CRC). As an important pathway of cellular energy metabolism, fatty acid metabolism plays an important role in cellular energy supply and oxidation balance, but presently, our understanding of the exact role of fatty acid metabolism in CRC is limited. Currently, no lipid metabolism therapy is available for the treatment of CRC. The establishment of a lipidmetabolism model regulated by oncogenes/tumor suppressor genes and associated with the clinical characteristics of CRC is necessary to further understand the mechanism of fatty acid metabolism in CRC. In this study, through multi-data combined with bioinformatic analysis and basic experiments, we introduced a tumor suppressor gene, EPHX2, which is rarely reported in CRC, and confirmed that its inhibitory effect on CRC is related to fatty acid degradation.
引用
收藏
页数：11
相关论文
共 49 条
[11]   Soluble epoxide hydrolase: Gene structure, expression and deletion [J].
Harris, Todd R. ;
Hammock, Bruce D. .
GENE, 2013, 526 (02) :61-74
[12]   Tumour fatty acid metabolism in the context of therapy resistance and obesity [J].
Hoy, Andrew J. ;
Nagarajan, Shilpa R. ;
Butler, Lisa M. .
NATURE REVIEWS CANCER, 2021, 21 (12) :753-766
[13]   EFEMP2 indicates assembly of M0 macrophage and more malignant phenotypes of glioma [J].
Huang, Lijie ;
Wang, Zheng ;
Chang, Yuanhao ;
Wang, Kuanyu ;
Kang, Xun ;
Huang, Ruoyu ;
Zhang, Ying ;
Chen, Jing ;
Zeng, Fan ;
Wu, Fan ;
Zhao, Zheng ;
Li, Guanzhang ;
Huang, Hua ;
Jiang, Tao ;
Hu, Huimin .
AGING-US, 2020, 12 (09) :8397-8412
[14]   Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk [J].
Ivashchenko, Oksana ;
Van Veldhoven, Paul P. ;
Brees, Chantal ;
Ho, Ye-Shih ;
Terlecky, Stanley R. ;
Fransen, Marc .
MOLECULAR BIOLOGY OF THE CELL, 2011, 22 (09) :1440-1451
[15]   Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma [J].
Jairath, Neil K. ;
Farha, Mark W. ;
Jairath, Ruple ;
Harms, Paul W. ;
Tsoi, Lam C. ;
Tejasvi, Trilokraj .
MELANOMA MANAGEMENT, 2020,
[16]   Peroxisome Metabolism in Cancer [J].
Kim, Jung-Ae .
CELLS, 2020, 9 (07) :1-19
[17]   Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats [J].
Koeners, Maarten P. ;
Wesseling, Sebastiaan ;
Ulu, Arzu ;
Lopez Sepulveda, Rocio ;
Morisseau, Christophe ;
Braam, Branko ;
Hammock, Bruce D. ;
Joles, Jaap A. .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2011, 300 (04) :E691-E698
[18]   Reprogramming of fatty acid metabolism in cancer [J].
Koundouros, Nikos ;
Poulogiannis, George .
BRITISH JOURNAL OF CANCER, 2020, 122 (01) :4-22
[19]   Metabolism of immune cells in cancer [J].
Leone, Robert D. ;
Powell, Jonathan D. .
NATURE REVIEWS CANCER, 2020, 20 (09) :516-531
[20]   CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Alct/mTOR/SRESP1c and P38/PPARα pathways [J].
Li, Jibin ;
Huang, Qichao ;
Long, Xiaoyu ;
Zhang, Jing ;
Huang, Xiaojun ;
Aa, Jiye ;
Yang, Hushan ;
Chen, Zhinan ;
Xing, Jinliang .
JOURNAL OF HEPATOLOGY, 2015, 63 (06) :1378-1389
12345